Filing Flows › Companies › ELI Lilly › Timeline
ELI Lilly stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+45.4% to $1,354.00
ELI Lilly (LLY) stock rose 45% over the last 252 sessions, to $1,354.00. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 8 Form 144 notices of planned sales, and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Oct 30, 2026 | Form 144 | Form 144: Lilly Endowment Inc. plans to sell $405M | +3.1% (+4.9% vs SPY) | −0.7% (+4.2% vs SPY) | — |
| Oct 29, 2026 | Earnings | Earnings: beat the EPS estimate by 17.9% | +6.4% (+6.8% vs SPY) | +9.6% (+10.3% vs SPY) | — |
| Oct 15, 2026 | Form 144 | Form 144: Lilly Endowment Inc. plans to sell $369M | +3.5% (+3.2% vs SPY) | +5.0% (+4.6% vs SPY) | — |
| Oct 7, 2026 | Form 144 | Form 144: Lilly Endowment Inc. plans to sell $347M | +2.7% (+2.9% vs SPY) | +0.8% (+0.9% vs SPY) | +20.3% (+21.9% vs SPY) |
| Aug 17, 2026 | Form 144 | Form 144: Patrik Jonsson plans to sell $7.6M | +0.3% (+0.7% vs SPY) | +6.2% (+7.5% vs SPY) | −3.8% (−1.3% vs SPY) |
| Aug 10, 2026 | Form 144 | Form 144: Donald Zakrowski plans to sell $2.4M | +3.8% (+3.9% vs SPY) | −0.3% (−0.7% vs SPY) | −5.2% (−4.3% vs SPY) |
| Aug 7, 2026 | Form 144 | Form 144: Anat Hakim plans to sell $11.9M | −0.5% (−1.1% vs SPY) | +1.4% (+0.2% vs SPY) | −3.5% (−3.7% vs SPY) |
| Aug 5, 2026 | Earnings | Earnings: beat the EPS estimate by 27.3% | +4.7% (+4.9% vs SPY) | +8.5% (+8.6% vs SPY) | +4.0% (+4.8% vs SPY) |
| Jul 7, 2026 | Form 144 | Form 144: Lilly Endowment Inc. plans to sell $372M | +2.9% (+3.4% vs SPY) | −1.5% (−1.2% vs SPY) | −7.3% (−9.9% vs SPY) |
| Jun 26, 2026 | Form 144 | Form 144: Lilly Endowment Inc. plans to sell $344M | +6.9% (+7.6% vs SPY) | +7.4% (+6.0% vs SPY) | +6.0% (+5.4% vs SPY) |
| Apr 30, 2026 | Earnings | Earnings: beat the EPS estimate by 25.9% | +9.3% (+8.4% vs SPY) | +14.8% (+11.7% vs SPY) | +26.3% (+20.2% vs SPY) |
| Feb 4, 2026 | Earnings | Earnings: beat the EPS estimate by 9.1% | +9.8% (+10.3% vs SPY) | +2.1% (+1.8% vs SPY) | −1.9% (−0.6% vs SPY) |
| Nov 21, 2025 | 8-K | Directors and officers: departures, appointments, pay | +1.0% (−0.5% vs SPY) | −0.2% (−3.3% vs SPY) | +1.1% (−3.5% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → ELI Lilly: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.